CoChat

Islets in Type 2 Diabetes: In Honor of Dr. Robert C. Turner

Open access
Bonner-Weir, Susan, O'Brien, Timothy D. · 2008 · Diabetes

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

The UK Prospective Diabetes Study (UKPDS) orchestrated by Robert Turner showed that, even with treatment, in type 2 diabetes a progressive β-cell dysfunction in a large number of patients was seen with the eventual need for additional oral antihyperglycemic medication and even insulin treatment (1). Such a progression could be from a continued loss of β-cells, a progressive functional change, or from the combination of both. During the decades when type 2 diabetes was considered mainly a disease of insulin resistance, many older pathology studies that focused on the islets in diabetic pancreata were ignored. However, with the renewed appreciation of the role of the pancreatic β-cell in type 2 diabetes, new studies have focused on what happens to the β-cells in type 2 diabetes. This perspectives in diabetes article will present what we know and still need to know about the islets in type 2 diabetes. ### Islet architecture in human pancreas. The islets of most mammalian species have a nonrandom pattern with a core of β-cells surrounded by a discontinuous mantle of non-β-cells one to three cells thick (2,3). However, islets of human and other primates have a more complex arrangement with many different islet profiles, including cloverleaf patterns. The profile differences have led to controversy about whether they actually have a mantle-core arrangement (3) or were random (4–6). In three dimensions, human islets can be considered as composites of several mantle-core subunits (7) or as lobulated with mantle-core lobules (3). In smaller islets, the rodent mantle core subunit arrangement is maintained, but in larger islets irregular fusion of such subunits are seen (Fig. 1). Most of the non-β-cells are found along penetrations of islet vasculature between subunits and the periphery (3,4), thus maintaining a mantle-core arrangement. Histologically, islets in the type 2 diabetic pancreas do not appear …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db07-1842

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Nonrandom distribution of glucagons-positive cells in human islets. In normal adult human pancreas, there is a nonrandom distribution of glucagon cells (brown) similar to that seen in rodents. In some small islets, glucagon cells form a mantle around a core of β-cells while larger islets seemed composed of irregular subunits of mantle-core organization. Immunoperoxidase staining for glucagon (brown); hematoxylin. Magnification bar = 50 um. (Please see http://dx.doi.org/10.2337/db07-1842 for a high-quality digital representation of this figure.)
FIG. 1. Nonrandom distribution of glucagons-positive cells in human islets. In normal adult human pancreas, there is a nonrandom distribution of glucagon cells (brown) similar to that seen in rodents. In some small islets, glucagon cells form a mantle around a core of β-cells while larger islets seemed composed of irregular subunits of mantle-core organization. Immunoperoxidase staining for glucagon (brown); hematoxylin. Magnification bar = 50 um. (Please see http://dx.doi.org/10.2337/db07-1842 for a high-quality digital representation of this figure.)CC BY-NC-ND · PubMed Central
FIG. 2. Amyloid deposits along the islet capillaries. In islets with severe amyloid deposits such as this one, there is a loss of insulin-positive (brown) β-cells and a distorted islet structure. Immunoperoxidase staining for insulin (brown); hematoxylin. Magnification bar = 25 um. (Please see http://dx.doi.org/10.2337/db07-1842 for a high-quality digital representation of this figure.)
FIG. 2. Amyloid deposits along the islet capillaries. In islets with severe amyloid deposits such as this one, there is a loss of insulin-positive (brown) β-cells and a distorted islet structure. Immunoperoxidase staining for insulin (brown); hematoxylin. Magnification bar = 25 um. (Please see http://dx.doi.org/10.2337/db07-1842 for a high-quality digital representation of this figure.)CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 69

Metadata

Authors
Bonner-Weir, S., & O'Brien, T. D.
Affiliations
  • Joslin Diabetes Center and Harvard Medical School, Boston, Massachusetts
  • Department of Veterinary Population Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota
Venue
Diabetes
Published
2008-11-01
Volume
57
Issue
11
Pages
2899-2904
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2170188899
Cited by
66
References
52
Citations by year
2024: 1 · 2023: 5 · 2022: 2 · 2021: 1 · 2020: 2 · 2018: 3 · 2017: 1 · 2016: 9 · 2015: 6 · 2014: 8 · 2013: 2 · 2012: 6
FWCI
7.04
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
type 2 diabetes, pancreatic islets, beta-cell dysfunction, islet architecture, beta cell destruction, insulin resistance, UK Prospective Diabetes Study
MeSH terms
Amyloid, Amyloidosis, Diabetes Mellitus, Type 2, Humans, Islets of Langerhans, Biomedical Research, History, 20th Century

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.